Repro Med Systems Inc
Ownership
Ownership Structure
Who owns Repro Med Systems Inc (KRMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.9% of the shares are freely tradable; institutional investors hold 57.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| First Light Asset Management, LLC | 7.34 | 3,387,902 | -10.1 | 06/30/2026 |
| Topline Capital Management LLC | 7.31 | 3,373,842 | -4.0 | 06/30/2026 |
| BlackRock Inc | 5.69 | 2,628,352 | +10.8 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.94 | 1,818,121 | +7.8 | 06/30/2026 |
| Geode Capital Management, LLC | 2.44 | 1,128,096 | +7.3 | 06/30/2026 |
| Simcoe Capital LLC | 1.79 | 827,393 | +2.0 | 06/30/2026 |
| Meros Investment Management, LP | 1.65 | 759,664 | -0.1 | 06/30/2026 |
| Lionhunter Capital Management, LLC | 1.50 | 693,139 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.72 | 1,254,742 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.48 | 1,146,316 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Manko Joseph M. Jr. | Director | 5,074,660 | 15,223,980 $ | Sep 30, 2026 | indirect |
| Kalbermatten Adam R | Chief Commercial Officer | 394,017 | 1,182,051 $ | Sep 8, 2026 | direct |
| Fletcher R John | Director | 239,836 | 719,508 $ | Oct 1, 2026 | direct |
| Matin Shahriar | Director | 106,263 | 318,789 $ | Oct 1, 2026 | direct |
| French Donna | Director | 103,633 | 310,899 $ | Oct 1, 2026 | direct |
| Cascella Robert | Director | 103,274 | 309,822 $ | Oct 1, 2026 | direct |
| Wholihan Edward | Director | 56,431 | 169,293 $ | Oct 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Wholihan Edward | Director | Other | 5,119 | 2.93 | 14,999 |
| Oct 1, 2026 | Matin Shahriar | Director | Other | 5,119 | 2.93 | 14,999 |
| Oct 1, 2026 | French Donna | Director | Other | 5,119 | 2.93 | 14,999 |
| Oct 1, 2026 | Fletcher R John | Director | Other | 7,679 | 2.93 | 22,499 |
| Oct 1, 2026 | Cascella Robert | Director | Other | 5,119 | 2.93 | 14,999 |
| Sep 30, 2026 | Manko Joseph M. Jr. | Director | Other | 5,119 | 0.00 | – |
| Sep 8, 2026 | Kalbermatten Adam R | Chief Commercial Officer | Buy | 32,000 | 3.16 | 101,120 |
| Jul 28, 2026 | Kalbermatten Adam R | Chief Commercial Officer | Other | 25,483 | 4.26 | 108,558 |
| Jul 28, 2026 | Kalbermatten Adam R | Chief Commercial Officer | Other | 75,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.